Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia

This study has been completed.
Janssen Korea, Ltd., Korea
Ministry of Health, Republic of Korea
Information provided by (Responsible Party):
Jin-Sang Yoon, Chonnam National University Hospital Identifier:
First received: January 22, 2009
Last updated: December 22, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):